**Record Sales in First Year as Sole CEO**
Colma B&H achieved its highest sales since its founding under the leadership of CEO Yoon Yeowon, reaching a revenue of 615.6 billion KRW last year. This milestone occurred during Yoon’s first year as the sole representative, countering Colma Holdings’ claims of poor performance. Yoon argued that the demand for resignation based on performance was a severe distortion of facts, emphasizing consistent sales growth despite the market downturn post-COVID-19.
Yoon also addressed past performance in the cosmetics sector, which struggled from 2018 to 2021. During this period, Colma B&H achieved significant growth and profitability within the group, yet none called for the resignation of Yoon Sanghyun, the Vice Chairman of Colma Holdings, for the cosmetics sector’s downturn. Yoon insisted that frequently replacing management in the consumer goods industry, which is sensitive to economic downturns, hampers the development of sustainable long-term strategies.
Colma B&H operated under the supervision of Colma Holdings, with the latter deeply involved in strategic decisions and frequently rejecting new business proposals aimed at growth. Colma Life & Health, cited as a business failure, began with approval and coordination with Yoon Donghan, Chairman of Korea Colma, and Vice Chairman Yoon.
Colma B&H focused on reforming its portfolio, enhancing R&D infrastructure, and improving efficiency across operations. It reported a 3.6 billion KRW operating profit in April alone, indicating a strong recovery in profitability from the second quarter onwards, with May’s profit exceeding 40% year-over-year growth.
Yoon transitioned the company’s focus from price competition to quality and technology-driven ODM strategies, achieving improved profitability and global expansion.
On the current dispute, Yoon apologized for the management conflict’s social impact, affirming commitment to Colma B&H’s vision as a leading global health-functional foods ODM company. He pledged to remain steadfast in achieving continued growth and stability.
Meanwhile, Yoon Donghan recently pursued legal action for the return of shares from Vice Chairman Yoon Sanghyun, leading the court to prohibit any transaction of the shares in question.